Initial | 12 Weeks | 24 Weeks | 48 Weeks | 72 Weeks | 96 Weeks | Mean# | |
---|---|---|---|---|---|---|---|
CRP | 0.292* | 0.477*** | 0.562*** | 0.521*** | 0.479*** | 0.227 | 0.573*** |
ESR | 0.235 | 0.491*** | 0.402** | 0.350* | 0.055 | 0.028 | 0.380** |
MHAQ | 0.138 | 0.183 | 0.210 | 0.250 | 0.246 | 0.005 | 0.272 |
Patients’ pain estimation† | 0.163 | 0.521*** | 0.428** | 0.405** | 0.472** | 0.025 | 0.531*** |
Patients’ global assessment†† | 0.152 | 0.500*** | 0.470*** | 0.382** | 0.563*** | 0.049 | 0.554*** |
Swollen joint count | 0.279* | 0.434** | 0.411** | 0.518*** | 0.266 | 0.214 | 0.523*** |
Tender joint count | 0.085 | 0.257 | 0.149 | 0.202 | 0.240 | 0.031 | 0.275* |
Physicians’ global assessment††† | 0.253 | 0.449*** | 0.478*** | 0.453*** | 0.419** | 0.101 | 0.524*** |
DAS28-(CRP) | 0.384** | 0.592*** | 0.610*** | 0.538*** | 0.447** | 0.293* | 0.618*** |
↵† Patients’ estimation of pain on visual analog scale (VAS).
↵†† Patients’ global assessment of disease activity on VAS.
↵††† Physicians’ global assessment of disease activity on VAS.
↵* p < 0.05;
↵** p < 0.01;
↵*** p < 0.001.
↵# Mean of values determined every 12 weeks over 96 week treatment period.